Enzymatic basis for the non-linearity of hepatic elimination of propranolol in the isolated perfused rat liver. 1992

R Ishida, and K Suzuki, and Y Masubuchi, and S Narimatsu, and S Fujita, and T Suzuki
Department of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Chiba University, Japan.

Propranolol (PL) metabolism was studied in the isolated perfused rat liver under single-pass and steady-state conditions. An attempt was made to predict the data observed in the isolated rat liver perfusion at PL infusion rates of 89-1317 nmol/min using the microsomal kinetic parameters obtained in our previous paper (Ishida et al., Biochem Pharmacol 43: 2489-2492, 1992) and the unbound PL fractions in rat liver microsomes and the perfusion medium. The values of kinetic parameters obtained in rat liver microsomes were corrected for the whole liver. Two groups of cytochrome P450 isozymes having high (Km < 0.5 microM)- and low (Km > 20 microM)-affinities participate in the metabolism of PL and sudan III pretreatment induces the low-affinity enzymes rather than the high-affinity enzymes in control rats. Of high-affinity isozyme(s) PL 4-hydroxylase and 7-hydroxylase made a major contribution to the overall activity, while for low-affinity isozymes PL 4-hydroxylase and N-desisopropylase did. A nonlinear relationship between the PL concentrations entering and leaving the liver was predicted from these corrected kinetic parameters using the venous equilibrium model. The outflow concentrations and the metabolic rates of PL for the predicted curves were over-estimated at higher inflow PL concentrations and under-estimated at higher substrate concentrations, respectively. On the other hand, the prediction for them was successfully carried out for the livers whose intrinsic clearance was altered due to the induction of low-affinity enzymes in PL metabolism by sudan III pretreatment. The outflow rates of 4-hydroxypropranolol showed a downward curvature at lower substrate concentrations, followed a linear rise in the livers from control rats, while the outflow rates of 5- and 7-hydroxypropranolol exhibited their respective limiting values. The outflow rates of 4-hydroxypropranolol and N-desisopropylpropranolol were enhanced markedly with increasing the outflow unbound concentration of PL by sudan III pretreatment. These results indicate that non-linear PL first-pass metabolism is due to the saturation of the reactions for the high-affinity enzymes among enzymes engaging in PL ring hydroxylations.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008433 Mathematics The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Mathematic
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

R Ishida, and K Suzuki, and Y Masubuchi, and S Narimatsu, and S Fujita, and T Suzuki
May 2000, Journal of pharmaceutical sciences,
R Ishida, and K Suzuki, and Y Masubuchi, and S Narimatsu, and S Fujita, and T Suzuki
January 1993, Clinical and experimental pharmacology & physiology,
R Ishida, and K Suzuki, and Y Masubuchi, and S Narimatsu, and S Fujita, and T Suzuki
August 1984, The Journal of pharmacology and experimental therapeutics,
R Ishida, and K Suzuki, and Y Masubuchi, and S Narimatsu, and S Fujita, and T Suzuki
November 1984, Xenobiotica; the fate of foreign compounds in biological systems,
R Ishida, and K Suzuki, and Y Masubuchi, and S Narimatsu, and S Fujita, and T Suzuki
March 1985, The Journal of pharmacy and pharmacology,
R Ishida, and K Suzuki, and Y Masubuchi, and S Narimatsu, and S Fujita, and T Suzuki
January 1985, Hepatology (Baltimore, Md.),
R Ishida, and K Suzuki, and Y Masubuchi, and S Narimatsu, and S Fujita, and T Suzuki
September 1987, Biochemical pharmacology,
R Ishida, and K Suzuki, and Y Masubuchi, and S Narimatsu, and S Fujita, and T Suzuki
March 1974, British journal of pharmacology,
R Ishida, and K Suzuki, and Y Masubuchi, and S Narimatsu, and S Fujita, and T Suzuki
February 1995, Drug metabolism and disposition: the biological fate of chemicals,
R Ishida, and K Suzuki, and Y Masubuchi, and S Narimatsu, and S Fujita, and T Suzuki
April 1988, Journal of pharmaceutical sciences,
Copied contents to your clipboard!